Adipose derived Stem Cell
Characteristic of Adipose derived Stem Cells
Adipose derived Stem Cells are called fat stem cells or ADSCs or ASCs.
Adipose derived Stem Cells(ADSCs) can be simply collected with liposuction.
A large amount of stem cells in small adipose tissue can be a useful ideal in regenerative medicine.
And large amounts of stem cells from small fat tissue can be obtained and those can be derived easily multiple times.
1. WHO |
• Adult |
2. WHAT |
• Liposuction the fat from hip, thigh, abdominal region |
3. WHEN |
• Always in good health or biopsy for patient’s disease diagnosis. |
4. WHERE |
• Collect – Plastic surgery
• Storage – Companies, hospitals, laboratories |
5. WHY |
The reason to collect and storage
• for public – research
• for private – self health against diseases |
6. HOW |
• Plantation to skin, vessels, bones after cultivation or non-cultivation |
7. Application (included diseases under investigation) |
• Multipotency of adipose derived stem cells can apply to various diseases.
Plastic surgery, Cosmetic surgery(CAL: Cell Assisted Lipotransfer), Wrinkle care, Cartilage damage, Joint inflammation, Urinary incontinence, Scatacratia, Lipoatrophy, Myocardial infarction, diabetes liver disease, ischemic peripheral vascular disease, multiple sclerosis, Perianal hematoma, Alzheimer’s disease, etc. |
Experimental factors to induce the differentiation of adipose tissue-derived stem cells
Differentiation factors |
Type of differentiation |
Clinical potential |
Insulin, IBMX (3-isobutil-1-methylxanthine), dexamethasone, rosiglitazone, indomethasone |
Adipogenic |
Reconstructive surgeries, skin filling |
bone morphogenetic protein, fibroblast growth factor, transforming growth factor, dexamethasone, insulin growth factor |
Chondrogenic |
Reconstructive surgeries, joint repair in degenerative diseases |
1,25 dihydroxycholecalciferol b β, glycerophosphate, ascorbic acid, bone morphogenetic protein 2, valproic acid |
Osteogenic |
Bone tissue regeneration in degenerative diseases, tumors and traumas |
? |
Myogenic |
Regeneration in degenerative diseases such as Duchenne muscular dystrophy |
stem cell factor, interleukin-3, interleukin-6 |
Cardiomyogenic |
Regeneration of cardiac muscle after acute myocardial infarction |
? |
Vascular / endothelial |
Neovascularization / ischemic diseases |
valproic acid, insulin, hydrocortisone, epidermal growth factor, FGF |
Neurogenic |
Chronic-degenerative diseases and central and peripheral nervous system traumas |
Activin-A, exedin-4, pentagastrin, hepatocyte growth factor, nicotinamide, glucose |
Pancreatic/endocrine |
Diabetes mellitus type 1 |
hepatocyte growth factor, oncostatin, dimethyl sulphoxide |
Hepatic |
Hepatic regeneration |
? |
Hematopoietic |
Hematopoetic reconstitution |
Source: Schäffler & Büchler, 2007
Leave a reply
You must be logged in to post a comment.